By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Neurotez, Inc. 

991 Highway 22
Suite 200A
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-998-1340 Fax: 908-864-8957



Company News
Bob Oliver Joins Neurotez, Inc. Board Of Directors 8/8/2017 9:54:38 AM
UPDATE: President & CEO Nikolaos Tezapsidis, Ph.D., Of Neurotez, Inc. To Be Interviewed Live On Clear Channel's "The Trader's Network Show" 3/23/2015 1:03:16 PM
Neurotez, Inc., GCA Therapeutics Strike $102.5 Million+ Alzheimer's Pact 5/21/2014 6:48:30 AM
Neurotez, Inc. Announces Grant of U.S. Patent 8,227,408 Around Its Leptin Therapy for Alzheimer’s Disease 7/27/2012 10:06:49 AM
Dr. Lex Van der Ploeg Has Been Elected to the Neurotez, Inc. Board of Directors 6/15/2012 10:12:31 AM
Neurotez, Inc. Reports Development of a Method to Isotype the Human TOMM40 Variable-Length Polymorphism 3/22/2011 10:45:44 AM
Neurotez, Inc., Announced That It Has Contracted with Paragon Bioservices for the Manufacturing of a Leptin Product for the Treatment of Alzheimer's Disease and Other Cognitive Disorders 12/20/2010 9:05:58 AM
New Study Published in JAMA Supports Neurotez, Inc. Plans for the Development of Leptin as a Therapy for AD 12/17/2009 9:53:13 AM
Neurotez, Inc. Awarded Multi-Million Dollar National Institutes of Health (NIH) Grant to Advance a Leptin Product into Clinical Trials for Treating Alzheimer's Disease 8/4/2009 10:03:42 AM
Neurotez, Inc. to Present at the 2008 Mid-Atlantic Capital (MAC) Conference 12/1/2008 10:50:35 AM